Emgality 120 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F1AJ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,152
Award facts
- Contract value 100% obligated
- $12,151.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 21, 2026, the Defense Logistics Agency awarded a $12,151.63 delivery order to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 22, 2026 and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Emgality is a calcitonin gene-related peptide (CGRP) antagonist indicated for migraine prevention, supporting the Defense Health Agency's pharmaceutical supply requirements for military healthcare systems.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement. The company's substantial IDC with DLA enables it to supply a comprehensive range of medications and medical commodities globally to support military treatment facilities and other government healthcare institutions. This delivery order exemplifies the routine task order activity under the broader prime vendor agreement, allowing the Defense Logistics Agency to efficiently procure essential specialty medications for beneficiary populations across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F1AJ8?
SPE2DR26F1AJ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1AJ8 worth?
The government has obligated $12,152 on SPE2DR26F1AJ8.
Is contract SPE2DR26F1AJ8 an order under another contract?
Yes. SPE2DR26F1AJ8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AJ8 competed?
The extent of competition for SPE2DR26F1AJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award